Progress in the work of the International AIDS society

  • August 14, 2015
  • News

IASJust few days ago, in the city of Vancouver was held the 8th Conference of the International AIDS society on pathogenesis, treatment and prevention of HIV. If we go back to 20 years, we recall that in that same place it was presented the tri-therapy or cocktail, and it was one of the most important events in the history of the epidemic.

The low flow of information in our region and poor participation perhaps speaks of the importance given to these issues. That’s why many colleagues are meeting to discuss how we are going to move forward in the countries of the region. Therefore, it urges these decisive contributions to be better informed.

This will definitely be a conference to remember, in addition to the 90-90-90 strategy, it will be remembered because it was the event in which pre-exposure prophylaxis (PrEP) went from clinical trials to be used in the real world. The Conference presented results of studies on the intermittent dosage of PrEP, presenting results on the daily intake versus intermittent decision (before sexual intercourse).

Given the widespread concern regarding the adherence to this kind of prophylaxis, various studies proved that people with a higher level of exposure were those using prophylaxis more consistently.

The new guidelines recommend treatment for all adults and adolescents with HIV –regardless their CD4 values, treatment for all children with HIV, treatment for all pregnant women with HIV, not only during pregnancy, but for life.

Quality of life, better health and response to treatment is intimately linked with the early onset of treatment, as well as reducing the possibility of transmission. Such is the degree of new evidence, that a research of the San Francisco General Hospital shows that offering HIV treatment to those diagnosed the same day that, achieves a higher rate of acceptance of treatment and it is faster to achieve an undetectable status.

This conference has brought many advances and evidence for prevention, diagnosis and treatment of HIV. However, this requires improvements in many aspects. We must get informed and read more in order to participate effectively in the design, implementation and monitoring of these strategies.